Literature DB >> 33830145

COVID 19 in Children: Gastrointestinal, Hepatobiliary and Pancreatic Manifestation.

K Fathema1, M N Hassan, M W Mazumder, M Benzamin, M Ahmed, M R Islam, N Haque, P K Sutradhar, A R Rahman, M Rukunuzzaman.   

Abstract

The most devastating pandemic of this era coronavirus disease-2019 (COVID-19) is caused by a novel virus named severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2). Although it is primarily a respiratory pathogen, it can also result in several extra-pulmonary manifestations includes gastrointestinal symptoms, hepatocellular injury. Angiotensin-converting enzyme-2 (ACE-2) receptor and transmembrane serine protease 2 (TMPRSS2), the entry receptor for the causative coronavirus SARS-CoV-2 is co-express in the gastrointestinal tract, hepatocyte, and cholangiocytes similar to the respiratory mucosa. The presence of these receptors facilitates the entry into the tissue and causes direct viral tissue damage, which is a proposed mechanism of injury. Diarrhoea, nausea, vomiting, abdominal discomfort are common gastrointestinal manifestations, whereas derangement of liver function tests is the most hepatic manifestation in COVID-19. In this article, we reviewed on SARS-CoV-2 disease COVID-19 regarding gastrointestinal, hepatic, and pancreatic manifestation, the mechanisms by which the virus may inflict damage, and their management perspective.

Entities:  

Mesh:

Year:  2021        PMID: 33830145

Source DB:  PubMed          Journal:  Mymensingh Med J        ISSN: 1022-4742


  3 in total

1.  Exploring the phytochemicals of Platycodon grandiflorus for TMPRSS2 inhibition in the search for SARS-CoV-2 entry inhibitors.

Authors:  Arun Bahadur Gurung; Mohammad Ajmal Ali; Joongku Lee; Reem M Aljowaie; Saeedah M Almutairi
Journal:  J King Saud Univ Sci       Date:  2022-06-09

Review 2.  Traditional Chinese Medicine in Treating Children With Coronavirus Disease 2019: A Scoping Review.

Authors:  Naifan Duan; Bin Liu; Xiaona Li; Yibai Xiong; Li Li; Yan Ma; Cheng Lu
Journal:  Front Pediatr       Date:  2022-07-19       Impact factor: 3.569

Review 3.  The Fight against COVID-19 on the Multi-Protease Front and Surroundings: Could an Early Therapeutic Approach with Repositioning Drugs Prevent the Disease Severity?

Authors:  Annamaria Vianello; Serena Del Turco; Serena Babboni; Beatrice Silvestrini; Rosetta Ragusa; Chiara Caselli; Luca Melani; Luca Fanucci; Giuseppina Basta
Journal:  Biomedicines       Date:  2021-06-23
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.